NCT00004817View on ClinicalTrials.gov

Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

385

Participants

Timeline

Start Date

February 28, 1991

Conditions
Post-Traumatic Seizure DisorderHead Injuries
Interventions
DRUG

phenytoin

DRUG

valproate sodium

All Listed Sponsors
collaborator

Harborview Injury Prevention and Research Center

OTHER

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH